Information  X 
Enter a valid email address

Biocompatibles Intl. (BII)

  Print      Mail a friend

Monday 24 January, 2011

Biocompatibles Intl.

Director/PDMR Shareholding


NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITY OR CONNECTED PERSONS

This form is intended for use by an issuer to make a RIS notification required
by DR 3.3

 

(1)           An issuer making a notification in respect of a transaction
relating to the shares or debentures of the issuer should complete boxes 1 to
16, 23 and 24.

(2)           An issuer making a notification in respect of a derivative
relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14,
16, 23 and 24.

(3)           An issuer making a notification in respect of options granted to
a director/person discharging managerial responsibilities should complete boxes
1 to 3 and 17 to 24.

(4)           An issuer making a notification in respect of a financial
instrument relating to the shares of the issuer (other than a debenture) should
complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

 

Please complete all relevant boxes should in block capital letters.

1. Name of the issuer                2. State whether the notification     
                                        relates to (i) a transaction       
                                        notified in accordance with DTR    
                                        3.1.2 R;                           
                                                                           
                                        (ii) a disclosure made in          
                                        accordance with LR 9.8.6 R(1), or; 
                                                                           
                                        (iii) a disclosure made in         
                                        accordance with section 793 of the 
                                        Companies act (2006)               
                                                                           
   Biocompatibles International plc     (i)                                
                                                                           
3. Name of person discharging        4. State whether notification relates 
   managerial responsibilities/         to a person connected with a person
   director                             discharging managerial             
                                        responsibilities/director named in 
                                        3 and identify the connected person
                                                                           
   Peter Geigle                         Not applicable                     
                                                                           
5. Indicate whether the notification 6. Description of shares (including   
   is in respect of a holding of the    class), debentures or derivatives  
   person referred to in 3 or 4         or financial instruments relating  
   above or in respect of a             to shares                          
   non-beneficial interest                                                 
                                                                           
   person referred to in 3. above        Ordinary shares  21 53/94 pence   
                                        each                               
                                                                           
7. Name of registered shareholders   8  State the nature of the transaction
   (s) and, if more than one, the                                          
   number of shares held by each of                                        
   them                                                                    
                                                                           
   as 3. above                          Sale                               
                                                                           

 

 

 

 

 

 

 

 

 

 

 

9.  Number of shares, debentures or      10. Percentage of issued class    
    financial instruments relating to        acquired (treasury shares of  
    shares acquired                          that class should not be taken
                                             into account when calculating 
                                             percentage)                   
                                                                           
                                                                           
                                                                           
11. Number of shares, debentures or      12. Percentage of issued class    
    financial instruments relating to        disposed (treasury shares of  
    shares disposed                          that class should not be taken
                                             into account when calculating 
                                             percentage)                   
                                                                           
             50,000 shares                   Total of   0.12%              
                                                                           
                                                                           
                                                                           
13. Price per share or value of          14. Date and place of transaction 
    transaction                                                            
                                                                           
        395p                                 19 January 2011               
                                                                           
                                                                           
                                                                           
15. Total holding following notification 16. Date issuer informed of       
    and total percentage holding             transaction                   
    following notification (any treasury                                   
    shares should not be taken into                                        
    account when calculating percentage)                                   
                                                                           
    730,929                                  21 January 2011               
                                                                           
    1.78%                                                                  
                                                                           

 

If a person discharging managerial responsibilities has been granted options by
the issuer complete the following boxes

17  Date of grant                        18. Period during which or date  
                                             on which it can be exercised 
                                                                          
                                                                          
                                                                          
19. Total amount paid (if any) for grant 20. Description of shares or     
    of the option                            debentures involved (class   
                                             and number)                  
                                                                          
                                                                          
                                                                          
21. Exercise price (if fixed at time of  22. Total number of shares or    
    grant) or indication that price is       debentures over which options
    to be fixed at the time of exercise      held following notification  
                                                                          
                                                                          
                                                                          
23. Any additional information           24. Name of contact and telephone
                                             number for queries           
                                                                          
                                             Ian Ardill                   
                                                                          
                                             Finance Director & Company   
                                             Secretary, Biocompatibles    
                                             International plc.           
                                                                          
                                             01252 732732                 
                                                                          

 

Name and signature of duly authorised officer of issuer responsible for   
making notification                                                       
                                                                          
IAN ARDILL                                                                
                                                                          
__________________________________________________________                
                                                                          
Date of notification 24  January 2011

a d v e r t i s e m e n t